M M Eibl|H M Wolf - JoVE Visualize

Showing results (111-120 of 127) with videos related to

Pageof 13

Sort By:

Cancer|January 15, 1995

Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of diseaseM Krainer, H Wolf, I Michl, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1988

Long-term influence of adjuvant therapy on natural killer cell activity in breast cancerE Tichatschek, C C Zielinski, C Müller, et al.

Acta Paediatrica Scandinavica|October 1, 1991

Phenotypes of peripheral blood lymphocytes during acute hepatitis AC Müller, I Gödl, J Göttlicher, et al.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 27, 1998

Prospective, double-blind, placebo-controlled, multicentre study on the effect of high-dose, intravenous immunoglobulin in children and adolescents with severe bronchial asthmaB Niggemann, W Leupold, A Schuster, et al.

Nederlands Tijdschrift Voor Geneeskunde|February 5, 2003

[Diagnostic image (120). A neonate with fever and a rash. Gianotti-Crosti-syndrome]P J G Zwijnenburg, B A van de Wiel, B H M Wolf

The Journal of Endocrinology|April 1, 1989

Effects of cyclosporin A upon humoral and cellular immune parameters in insulin-dependent diabetes mellitus type I: a long-term follow-up studyC Müller, C C Zielinski, W Kalinowski, et al.

British Journal of Haematology|June 20, 1998

Mutation analysis by a non-radioactive single-strand conformation polymorphism assay in nine families with X-linked severe combined immunodeficiency (SCIDX1)G S Wengler, S Giliani, M Fiorini, et al.

Nederlands Tijdschrift Voor Geneeskunde|November 23, 2012

[Burns in children: child abuse or another cause?]Roelof van Ewijk, Moniek E op de Coul, A H Rian Teeuw, et al.

AIDS (London, England)|August 28, 1999

Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial. European Multinational IMMUNO AIDS Vaccine Study GroupF D Goebel, J W Mannhalter, R B Belshe, et al.

Vaccine|March 10, 1998

Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, M J McElrath, T J Matthews, et al.

Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:

Pageof 13

Cancer|January 15, 1995

Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of diseaseM Krainer, H Wolf, I Michl, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1988

Long-term influence of adjuvant therapy on natural killer cell activity in breast cancerE Tichatschek, C C Zielinski, C Müller, et al.

Acta Paediatrica Scandinavica|October 1, 1991

Phenotypes of peripheral blood lymphocytes during acute hepatitis AC Müller, I Gödl, J Göttlicher, et al.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 27, 1998

Prospective, double-blind, placebo-controlled, multicentre study on the effect of high-dose, intravenous immunoglobulin in children and adolescents with severe bronchial asthmaB Niggemann, W Leupold, A Schuster, et al.

Nederlands Tijdschrift Voor Geneeskunde|February 5, 2003

[Diagnostic image (120). A neonate with fever and a rash. Gianotti-Crosti-syndrome]P J G Zwijnenburg, B A van de Wiel, B H M Wolf

The Journal of Endocrinology|April 1, 1989

Effects of cyclosporin A upon humoral and cellular immune parameters in insulin-dependent diabetes mellitus type I: a long-term follow-up studyC Müller, C C Zielinski, W Kalinowski, et al.

British Journal of Haematology|June 20, 1998

Mutation analysis by a non-radioactive single-strand conformation polymorphism assay in nine families with X-linked severe combined immunodeficiency (SCIDX1)G S Wengler, S Giliani, M Fiorini, et al.

Nederlands Tijdschrift Voor Geneeskunde|November 23, 2012

[Burns in children: child abuse or another cause?]Roelof van Ewijk, Moniek E op de Coul, A H Rian Teeuw, et al.

AIDS (London, England)|August 28, 1999

Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial. European Multinational IMMUNO AIDS Vaccine Study GroupF D Goebel, J W Mannhalter, R B Belshe, et al.

Vaccine|March 10, 1998

Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, M J McElrath, T J Matthews, et al.

Pageof 13